(Q39045016)

8 September 2017

Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A. (English)

1 reference

8 September 2017

1 reference

Oleg F Sharifov

1

1 reference

8 September 2017

Gaurav Nayyar

2

1 reference

8 September 2017

Vladimir V Ternovoy

3

1 reference

8 September 2017

Mayakonda N Palgunachari

4

1 reference

8 September 2017

David W Garber

5

1 reference

8 September 2017

Gm Anantharamaiah

6

1 reference

8 September 2017

Himanshu Gupta

7

1 reference

8 September 2017

9 December 2013

1 reference

8 September 2017

1 reference

8 September 2017

20

1 reference

8 September 2017

8

1 reference

8 September 2017

867-880

1 reference

The immunopathogenesis of sepsis

8 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Oxidative stress in septic shock and disseminated intravascular coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Severe sepsis and septic shock: the role of gram-negative bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Chlamydial lipopolysaccharide (cLPS) is present in atherosclerotic and aneurysmal arterial wall--cLPS levels depend on disease manifestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Atherogenic lipoprotein parameters in patients with aggressive periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Chlamydial LPS and high-sensitivity CRP levels in serum are associated with an elevated body mass index in patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Adipocyte-macrophage interaction may mediate LPS-induced low-grade inflammation: potential link with metabolic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Distribution and kinetics of lipoprotein-bound endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Apolipoprotein E: far more than a lipid transport protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Structure and function of HDL mimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Apolipoprotein E mimetics and cholesterol-lowering properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Apolipoprotein E mimetic Peptide dramatically lowers plasma cholesterol and restores endothelial function in watanabe heritable hyperlipidemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Synthetic peptide analogs of apolipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

In vivo protection against endotoxin by plasma high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Apolipoprotein A-I mimetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

4F, apolipoprotein AI mimetic peptide, attenuates acute lung injury and improves survival in endotoxemic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Effect of an arginine-rich amphipathic helical peptide on plasma cholesterol in dyslipidemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

The recycling of apolipoprotein E in macrophages: influence of HDL and apolipoprotein A-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Apolipoprotein E suppresses the type I inflammatory response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

The receptor-binding region of human apolipoprotein E has direct anti-infective activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Lipopolysaccharide-binding protein critically regulates lipopolysaccharide-induced IFN-beta signaling pathway in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Aggregates are the biologically active units of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

A high-fat diet is associated with endotoxemia that originates from the gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Biophysical characterization of endotoxin inactivation by NK-2, an antimicrobial peptide derived from mammalian NK-lysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Regulation of pattern recognition receptors by the apolipoprotein A-I mimetic peptide 4F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Human leucocyte heparan sulphate proteoglycans and their roles in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

The role of heparan sulphate in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

DAMPening inflammation by modulating TLR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

Toll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of Bacteroides fragilis lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913514621

21 January 2018

Identifiers

DOI

10.1177/1753425913514621

1 reference

8 September 2017

1 reference